GNRHR and polycystic ovary syndrome: Pregnant patients with PCOS have statistically higher serum concentrations of AMH, which may disrupt the GnRH receptor signaling and placental metabolism, conditioning the offspring to develop PCOS neuroendocrine and reproductive phenotype later in life (Tata et al., 2018; Piltonen et al., 2019).